Nepafenac Ophthalmic Suspension, 0.3%

DRUG4 trials

Sponsors

Alcon Research

Conditions

CataractNon-Proliferative Diabetic Retinopathy

Phase 2

Nepafenac 0.3% Two Study

CompletedNCT01318499

Alcon ResearchCataract

Start: 2011-03-31End: 2011-09-30Updated: 2012-12-17

Phase 3

Confirmatory Study Nepafenac 0.3%

CompletedNCT01109173

Alcon ResearchCataract

Start: 2010-06-30Updated: 2012-11-30

Nepafenac Once Daily for Macular Edema - Study 1

CompletedNCT01853072

Alcon ResearchCataract, Non-Proliferative Diabetic Retinopathy

Start: 2013-06-30End: 2015-05-31Updated: 2016-08-03

Nepafenac Once Daily for Macular Edema - Study 2

CompletedNCT01872611

Alcon ResearchCataract, Non-Proliferative Diabetic Retinopathy

Start: 2013-06-30End: 2015-05-31Updated: 2016-08-02